Therapeutic Effect of Repetitive Transcranial Magnetic Stimulaton on Tinnitus

Not Applicable

Completed

• Conditions: Patients With Subjective Tinnitus
• Interventions: Device: sham repetitive Transcranial Magnetic Stimulation; Device: real repetitive Transcranial Magnetic Stimulation

• Registration Number: NCT02071732
• Lead Sponsor: Dongtan Sacred Heart Hospital

Brief Summary

The purpose of this study is to determine whether repetitive transcranial magnetic stimulation (rTMS) is effective in the treatment of tinnitus.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-02
• Study First Submitted: 2014-02-19
• Study First Submitted QC: 2014-02-25
• Study First Posted: 2014-02-26
• Status Verified: 2021-08
• Primary Completion: 2021-08
• Study Completion: 2021-08
• Last Update Submitted: 2021-08-17
• Last Update Posted: 2021-08-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 19

Inclusion Criteria

• Subjective tinnitus
• Age 18 years and older

Exclusion Criteria

• Meniere, conductive hearing loss, objective tinnitus
• History of seizure disorder or epilepsy
• Clinically relevant psychiatric comorbidity
• Previous symptomatic stroke
• Surgically or traumatically implanted foreign bodies such as a pacemaker, an implanted medication pump, a metal plate in the skull, or metal inside the skull or eyes (other than dental appliances or fillings), intracardiac lines that may pose a physical hazard during magnetic stimulation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Sham rTMS	sham repetitive Transcranial Magnetic Stimulation	Sham rTMS is sham continuous theta burst stimulation.
Real rTMS	real repetitive Transcranial Magnetic Stimulation	Real rTMS is real continuous theta burst stimulation.

Primary Outcome Measures

Name	Time	Method
Tinnitus handicap inventory score	Before (- six months) and after (+ 5 days) rTMS interventions	Primary outcomes will be measured twice. One is before, and the other is after 5-day rTMS interventions. Baseline primary outcome will be acceptable if it is done within the prior 6 months of 1st rTMS. Follow-up primary outcome will be done within the five days after 5th rTMS.

Trial Locations

Locations (1)

Department of Neurology, and Department of Otorhinolaryngology-Head & Neck Surgery Dongtan Sacred Heart Hospital; 🇰🇷 Hwaseong-si, Gyeonggi-do, Korea, Republic of